Trial Profile
A study to compare glycaemic variations by continuous glucose monitoring in Japanese patients with type-1 diabetes receiving insulin-degludec vs insulin-detemir
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2017
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 01 Mar 2017 Results (n=10) published in the Expert Opinion on Pharmacotherapy.
- 23 Mar 2016 New trial record